What does Guardian Bio do?
Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
Guardian Bio company profile and hiring status. Explore Guardian Bio careers information, funding context, and official application links when available. Founded 2022. Team size: 1-10. Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.
Company profile last updated on May 31, 2026.
Guardian Bio careers and hiring status: no open roles are currently listed here, but you can review the company profile and check the official career page for the latest openings. Official careers page
Guardian Bio is an biotech company. Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
Open positions
Check the official career page, browse adjacent companies, or subscribe for new openings.
Candidate questions
Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
Guardian Bio does not have open roles listed on our platform right now. Visit the official company website or career page for the latest openings. You can also subscribe to our newsletter to get notified when new roles are posted.
Guardian Bio has raised $500K in total. The latest known stage is Seed.
Guardian Bio reports an employee count of 1-10.
Guardian Bio was founded in 2022.
Guardian Bio is associated with Biotech, Healthcare, Medical, AI, Machine Learning, Analytics, and other related technologies.
Company context